SS-31 10mg - single vial

$25.00

SS-31, also known as Elamipretide, is a mitochondria-targeting peptide designed to improve cellular energy production and reduce oxidative stress. Unlike many peptides that work through hormone receptors, SS-31 binds to cardiolipin within the inner mitochondrial membrane, helping stabilize mitochondrial function and improve ATP production. It has been extensively studied for age-related decline, cardiovascular health, muscle performance, fatigue, metabolic disorders, and mitochondrial dysfunction.

Common Research Dosing Protocol:

  • 2-5 mg daily

  • Common starting dose: 2 mg daily

  • Typical performance/recovery protocol: 5 mg daily

  • Typical cycle length: 4-12 weeks

Administration:

  • Subcutaneous injection

  • Usually administered once daily

  • Often taken in the morning due to reports of increased energy and reduced fatigue

Storage:

  • Refrigerate at 36-46°F (2-8°C) after reconstitution

  • Protect from light

  • Do not freeze

  • Use sterile technique for all withdrawals

Notes:
SS-31 is frequently researched for:

  • Mitochondrial function and ATP production

  • Exercise endurance and recovery

  • Reduction of oxidative stress

  • Cardiovascular support

  • Healthy aging

  • Improved metabolic efficiency

It is commonly stacked with MOTS-c, AICAR, Retatrutide, or Tesamorelin in metabolic and performance-focused protocols. Many users report improvements in energy levels, workout endurance, recovery capacity, and reduced fatigue within 1-3 weeks, though mitochondrial adaptations may continue to develop over longer periods. Unlike stimulants, SS-31 typically enhances cellular energy production without causing jitters or elevated heart rate.

SS-31, also known as Elamipretide, is a mitochondria-targeting peptide designed to improve cellular energy production and reduce oxidative stress. Unlike many peptides that work through hormone receptors, SS-31 binds to cardiolipin within the inner mitochondrial membrane, helping stabilize mitochondrial function and improve ATP production. It has been extensively studied for age-related decline, cardiovascular health, muscle performance, fatigue, metabolic disorders, and mitochondrial dysfunction.

Common Research Dosing Protocol:

  • 2-5 mg daily

  • Common starting dose: 2 mg daily

  • Typical performance/recovery protocol: 5 mg daily

  • Typical cycle length: 4-12 weeks

Administration:

  • Subcutaneous injection

  • Usually administered once daily

  • Often taken in the morning due to reports of increased energy and reduced fatigue

Storage:

  • Refrigerate at 36-46°F (2-8°C) after reconstitution

  • Protect from light

  • Do not freeze

  • Use sterile technique for all withdrawals

Notes:
SS-31 is frequently researched for:

  • Mitochondrial function and ATP production

  • Exercise endurance and recovery

  • Reduction of oxidative stress

  • Cardiovascular support

  • Healthy aging

  • Improved metabolic efficiency

It is commonly stacked with MOTS-c, AICAR, Retatrutide, or Tesamorelin in metabolic and performance-focused protocols. Many users report improvements in energy levels, workout endurance, recovery capacity, and reduced fatigue within 1-3 weeks, though mitochondrial adaptations may continue to develop over longer periods. Unlike stimulants, SS-31 typically enhances cellular energy production without causing jitters or elevated heart rate.